Refractory UC of the bladder cancer or transitional cell carcinoma arising in another location of the urinary tract, including urethra, ureter, and renal pelvis with positive FGFR3 expression on IHC. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.